These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 2433542)

  • 41. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of congestive heart failure: is the role of positive inotropic therapy fading?
    Futterman LG; Lemberg L
    Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newer inotropic agents.
    Sharpe DN
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):215-8. PubMed ID: 6087050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The new inotropic phosphodiesterase inhibitors.
    el Allaf D; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S69-79. PubMed ID: 6085243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 49. Inotropic therapy for heart failure--an unfulfilled promise.
    Curfman GD
    N Engl J Med; 1991 Nov; 325(21):1509-10. PubMed ID: 1944430
    [No Abstract]   [Full Text] [Related]  

  • 50. [Inotropic agents].
    Sasayama S
    Nihon Rinsho; 2003 May; 61(5):807-14. PubMed ID: 12755007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.
    Katz AM
    Circulation; 1986 Mar; 73(3 Pt 2):III184-90. PubMed ID: 2417747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of inotropes in the critical care setting.
    Löllgen H; Drexler H
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Positive inotropic substances. Possible use in heart failure in the aged].
    Michel D
    Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enoximone as a bridge to heart transplantation: the Utah experience.
    O'Connell JB; Gilbert EM; Renlund DG; Bristow MR
    J Heart Lung Transplant; 1991; 10(3):477-81. PubMed ID: 1830222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Inotropic drugs in treatment of heart failure--advantages and adverse reactions].
    Witkowska M
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):936-40. PubMed ID: 1300581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Postoperative cardiac insufficiency. The value of enoximone].
    Albo C; Baron JF; Coriat P; Souguir S; Viars P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():87-93. PubMed ID: 2147841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.